Medical
Surgical
Systems $766,401 $675,741 13.4 3.7 9.7
Diabetes
Care 278,736 234,491 18.9 7.1 11.8
Pharmaceutical
Systems 563,969 462,540 21.9 8.3 13.6
Ophthalmic
Systems 41,137 33,461 22.9 11.6 11.3
TOTAL $1,650,243 $1,406,233 17.4 6.0 11.4
BD DIAGNOSTICS
Preanalytical
Systems $408,031 $342,941 19.0 7.5 11.5
Diagnostic
Systems 358,019 282,571 26.7 15.8 10.9
TOTAL $766,050 $625,512 22.5 11.3 11.2
BD BIOSCIENCES
Cell
Analysis(1) $421,095 $339,146 24.2 13.0 11.2
Discovery
Labware 110,616 94,987 16.5 5.4 11.1
TOTAL $531,711 $434,133 22.5 11.4 11.1
TOTAL
INTER-
NATIONAL $2,948,004 $2,465,878 19.6 8.3 11.3
(1) Cell Analysis consists of the Immunocytometry Systems and the
Pharmingen units that were previously reported separately.
BECTON DICKINSON AND COMPANY
SUPPLEMENTAL REVENUE INFORMATION
REVENUES BY BUSINESS SEGMENTS AND UNITS
Nine Months Ended June 30, (continued)
(Unaudited; Amounts in thousands)
Total
% Change
2008 2007 Reported FX Neutral FX Impact
BD MEDICAL
Medical
Surgical
Systems $1,495,553 $1,387,286 7.8 3.1 4.7
Diabetes
Care 576,807 514,746 12.1 6.7 5.4
<| SOURCE BD (Becton, Dickinson and Company) Copyright©2008 PR Newswire. All rights reserved |